The general trend indicated that higher doses of testosterone were more likely to result in azoospermia than lower doses, however a dose-response effect was not consistently seen. Normal sperm production depends on a functionally intact hypothalamic-pituitary-gonadal axis with normal secretion of pituitary LH and FSH to support intratesticular testosterone production and spermatogenesis. There were inconsistently defined end points to categorize severe cardiac events, which included 'softer' endpoints (e.g., edema, tachycardia, hypertension) along with myocardial infarction and stroke.194 The statistical analysis did not account for confounding factors; the duration of follow-up varied widely, from 12 weeks to 3 years; and many of the trials were not powered to detect cardiac events as primary endpoints, rather they were catalogued as adverse outcomes. Thresholds for low testosterone were not universal. One RCT by Maggi et al. followed 715 testosterone deficient men for 12 weeks to evaluate the effects of a 2% transdermal testosterone agent on sex drive and energy. Of these, 14 biopsies (54%) revealed no cancer, and no patients required additional biopsy for clinical concerns.357 However, the two groups had a more negligible difference in LDL cholesterol levels. Increased peripheral glucose uptake and better insulin sensitivity may result from testosterone’s ability to promote the translocation of glucose transporter type 4 (GLUT4) to myocyte membranes. New studies have found that a high percentage of men with type 2 diabetes also suffer from hypogonadism. In contrast, the pre-treatment values for the placebo group were 7.52 ± 1.08, whereas the post-treatment values were 7.59 ± 1.19. The main purpose of testosterone therapy is to return patients to normal physiological testosterone levels and provide relief of symptoms or signs. Testosterone deficient patients should be informed that low testosterone levels place them at risk for these major cardiovascular events and clinicians should assess all testosterone deficient patients for ASCVD risk factors, both fixed (e.g., older age, male gender) and modifiable (e.g., dyslipidemia, hypertension, diabetes, current cigarette smoking). Patients with testosterone deficiency who maintain testosterone levels in the normal range while on testosterone therapy should have their PSA levels tested, utilizing a shared decision-making approach, in accordance with the AUA's Early Detection of Prostate Cancer Guideline. It is the opinion of this Panel that serum PSA levels should be measured prior to the commencement of testosterone therapy in patients over 40 years of age in order to minimize the risk of prescribing testosterone therapy to men with occult prostate cancer. Part of this effort includes the availability of serum-based reference material from pooled sera available from the National Institute for Standards and Technology for testosterone and a hormone standardization program using liquid chromatography/mass spectrometry (LCMS) offered by CDC. The differences in testosterone methodologies have led to considerable effort by a variety of parties including the Centers for Disease Control (CDC) and the College of American Pathologists towards harmonization of assays. It is bound to albumin (50%, loosely-bound), sex hormone-binding globulin (SHBG, 44%, tightly-bound), corticotropin-binding globulin (4%, loosely-bound), and approximately 2% circulates as free testosterone.9 The free and loosely-bound testosterone fractions combined are known as bioavailable testosterone.Testosterone assays are plagued by variability in results. Testosterone is the predominant androgen in males and is involved in a multitude of physiological and biochemical processes throughout the body. Early morning samples from each subject's most recent and previous 3 visits as well as those from 10, 15, 20, 25, and 30 years prior were analyzed (3,565 samples total with a mean of 4 samples per patient). Specifically, the odds ratio for developing ED in men with total testosterone 6 used a single question to define ED and also showed an increase in ED risk as total testosterone levels decreased. In a small study of young men with acute respiratory infections, mean total testosterone levels declined by 10%, with some cohorts experiencing reductions of up to 30%.25 It was decided that a cut-off value was critical to define testosterone deficiency and that this cut-off be based on at least two total testosterone levels drawn in an early morning fashion at the same laboratory using the same assay. Clinicians should adjust testosterone therapy dosing to achieve a total testosterone level in the middle tertile of the normal reference range. Inadequate therapy might leave the patient at increased risk of undertreated HG, such that trials need to be assessed in terms of adequate compliance and evidence of sustained treatment to therapeutic levels 47,76. Ding et al. demonstrated that baseline testosterone levels correlated positively with glycemic variability, expressed as standard deviation of mean blood glucose (SDBG), in Asian men with DM; in particular, a total testosterone level above 14.76 mmol/L (4.21 ng/mL) was a predictor of glycemic variability, according to ROC curves. This leads to high blood sugar levels, which, if uncontrolled, can cause complications like heart disease, kidney damage, nerve damage, and eye problems. It occurs when the body becomes resistant to insulin, a hormone that helps regulate blood sugar, or when the pancreas doesn’t produce enough insulin. While testosterone is mainly thought of in relation to male health, it also plays a role in women’s bodies, although at lower levels.. The largest RCT conducted to date exclusively in men with T2DM is the BLAST study (an acronym of the towns and cities involved-Birmingham, Lichfield, Tamworth, Atherstone and Sutton Coldfield). The Moscow study involved 184 obese men randomised to long acting TU for 26 weeks found marked reductions in weight, BMI, waist circumference, and inflammatory markers but no reduction in fasting glucose . We therefore need alternative strategies as eventually many patients fail with a regime dedicated to lifestyle change and hypoglycaemic drugs.|But one of the most important functions of testosterone is its role in regulating insulin and glucose (sugar) in the body. Finally, we’ll touch on the long-term risks of having both low testosterone and diabetes. One treatment option for low testosterone is testosterone replacement therapy (TRT). There is also type 1 diabetes, where the body stops making insulin altogether, but this is less common than type 2 diabetes.|These studies suggest that taking no action, or not measuring testosterone at all, is likely to have severe implications for men with T2DM and low testosterone . There was no analysis of data related to insulin resistance and no attempt to conduct a sub-analysis of men with cardiometabolic disease. In contrast a comprehensive meta-analysis of 156 RCTS by Huo et al concluded that there the prescription of testosterone supplementation for low-T for CV health, sexual function, physical function, mood, or cognitive function is without support from RCT. The inclusion or exclusion of a small number of controversial studies can profoundly alter the conclusions 68,70. Injections of different esters are grouped together, and USA studies do not include long acting TU, a major therapy in Europe for over a decade 56,66. Many studies on this subject exclude the first 6 months on the basis that events in this period are likely to be due to the untreated condition rather than the impact of therapy .} There does appear to be a trend towards lower total testosterone and a diagnosis of ED. A challenge in making the diagnosis of testosterone deficiency is that many of the symptoms reported by patients are non-specific and might be related to conditions other than low testosterone. Total testosterone absence of signs and/or symptoms increases the likelihood of making a false diagnosis and reduces the potential benefit of testosterone therapy. Given that the direct method for free testosterone measurement is also time-consuming and labor intensive, calculation derived free testosterone measurement is more commonly used, however there is considerable variation in total testosterone assays as well as the clinical conditions that affect serum albumin and SHBG, all of which impact this measurement. The Panel recommends that clinicians use the same laboratory with the same method/instrumentation for serial total testosterone measurement. There is a great deal of variability across studies with respect to the forms of testosterone measured (total versus free), the assays utilized to measure testosterone, the time of day when the sample is obtained, and the number of testosterone measurements taken. As an example, a total testosterone value of 250 ng/dL may be considered low based on the current guideline but be marked within the normal range by the laboratory. In the first group we used diet, physical activity (lifestyle intervention implies reduced calorie diet - the reduction of daily calorie intake to 1800 to 2000 calories – and this was selected individually), patient’s antidiabetic therapy and TRT (testosterone undecanoate 250 mg/ml intra-muscularly once every 3 months). Eighty-five subjects, with age range 41 to 65 years and BMI from 27.0 to 48.0 kg/m2, were randomized in a placebo-controlled study. One hundred and twenty-five male patients with diabetes mellitus were tested; subject enrollment was recorded for the period from 2010 until the end of 2013, at the LTD ‘National Institute of Endocrinology’ (Tbilisi, Georgia). Other recent cross-sectional studies included larger numbers of men with diabetes (between 100 and 580), but were limited by the absence of a non-diabetic control group. As it has been previously shown, patients with T2DM have a frequent occurrence of hypogonadotrophic hypogonadism as reflected in low plasma concentrations of testosterone and inappropriately low luteinizing hormone (LH) and follicle-stimulating hormone (FSH) . Studies in laboratory animals support the hypothesis that diabetes has detrimental effects on testicular function; reduction in both Leydig cell number and testosterone secretion has been reported . Low concentrations of endogenous androgens have been linked with IR, which is an important upstream driver for metabolic abnormalities such as hyperglycemia, hypertension, or dyslipidemia, and increased cardiovascular risk 7,8. The highest level of evidence comes from RCTs, but many are of insufficient duration, often less than 26 seeks and sometimes only 12 weeks (mean, 33.5 weeks) . Despite these weaknesses, the effect of testosterone replacement therapy (TRT) was close to significance, even though the exposure to testosterone was only 3 months. The IIEF-EF score increased by 2.64 points vs. placebo, but sexual activity increased to 4 times per week, along with significant increase in sexual desire. In the testosterone trials , involving older mean (mean age, 72 years) 37% of 780 recruited patients had T2DM. The TIMES-2 study involved 12 months RCT of 2% testosterone gel in 220 men (mean age, 59 years) with either T2DM (62%) or metabolic syndrome with a 4.87-point improvement in IIEF-EF score from a baseline of 12 points.